[HTML][HTML] One-step synthesis of site-specific antibody–drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates

W Shi, W Li, J Zhang, T Li, Y Song, Y Zeng… - … Pharmaceutica Sinica B, 2022 - Elsevier
Glycosite-specific antibody‒drug conjugatess (gsADCs), harnessing Asn297 N-glycan of
IgG Fc as the conjugation site for drug payloads, usually require multi-step glycoengineering …

One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates

W SHI, W LI, J ZHANG, T LI, Y SONG… - Acta Pharmaceutica …, 2022 - pesquisa.bvsalud.org
Glycosite-specific antibody‒drug conjugatess (gsADCs), harnessing Asn297 N-glycan of
IgG Fc as the conjugation site for drug payloads, usually require multi-step glycoengineering …

One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates.

W Shi, W Li, J Zhang, T Li, Y Song, Y Zeng… - Acta Pharmaceutica …, 2021 - europepmc.org
Glycosite-specific antibody‒drug conjugatess (gsADCs), harnessing Asn297 N-glycan of
IgG Fc as the conjugation site for drug payloads, usually require multi-step glycoengineering …

[PDF][PDF] One-step synthesis of site-specific antibodyedrug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates

W Shi, W Li, J Zhang, T Li, Y Song, Y Zeng, Q Dong… - 2022 - glycanlink.com
Glycosite-specific antibody‒drug conjugatess (gsADCs), harnessing Asn297 N-glycan of
IgG Fc as the conjugation site for drug payloads, usually require multi-step glycoengineering …

One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates

W Shi, W Li, J Zhang, T Li, Y Song… - Acta …, 2022 - pubmed.ncbi.nlm.nih.gov
Glycosite-specific antibody‒drug conjugatess (gsADCs), harnessing Asn297 N-glycan of
IgG Fc as the conjugation site for drug payloads, usually require multi-step glycoengineering …

[HTML][HTML] One-step synthesis of site-specific antibody–drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates

W Shi, W Li, J Zhang, T Li, Y Song, Y Zeng… - Acta Pharmaceutica …, 2022 - ncbi.nlm.nih.gov
Glycosite-specific antibody‒drug conjugatess (gsADCs), harnessing Asn297 N-glycan of
IgG Fc as the conjugation site for drug payloads, usually require multi-step glycoengineering …

One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates

SHI Wei, LI Wanzhen, J ZHANG… - Acta Pharmaceutica …, 2022 - pesquisa.bvsalud.org
Glycosite-specific antibody‒drug conjugatess (gsADCs), harnessing Asn297 N-glycan of
IgG Fc as the conjugation site for drug payloads, usually require multi-step glycoengineering …